The company plans ‌to sell less than 5% of its shares in its upcoming $75 bln IPO. That may leave ​a giant overhang of insiders desperate ​for their turn. Spreading exits over ⁠16 different dates should slow the deluge, ​but may just replace it with chronic ​pain.